Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus

Blood Coagulation and Fibrinolysis

Volumn 19, Issue 1, 2008, Pages 7-13

  El Ghoroury, Eman A ^a,b   El Din, Hesham Gamal ^a   Abdel Kader, Mona ^a   Ragab, Shadia ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b NONE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; LIPOPOLYSACCHARIDE; PROCOAGULANT; THROMBOPLASTIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC PATIENT; FEMALE; GLUCOSE BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERLIPIDEMIA; MALE; MEDICAL EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FACTOR VIIA; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS; MALE; MIDDLE AGED; MONOCYTES; THROMBOPLASTIN;

EID: 37848999307     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000304148.26525.da     Document Type: Article

References (24)

1. Carr ME. Diabetes mellitus. A hypercoagulable state. J Diabetes Complicat 2001; 15:44-54.
2. Taubman MB, Fallon JT, Schester AD. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997; 78:200-205.
3. Motton DD, Mackman N, Tilley RE, Rutledge JC. Postprandial elevation of tissue factor antigen in the blood of healthy adults. Thomb Haemost 2005; 94:504-509.
4. Leurs PB, Van Oerle R, Wbuttel BH, Hamulyak K. Increased tissue factor pathway inhibitor (TFPI) and coagulation in patients with insulin-dependent diabetes mellitus. Thromb Haemost 1997; 77:472-476.
5. Reverter JL, Reverter JC, Tassies D, Rius F, Monteagudo J, Rubiies-Prat J, et al. Thrombomodulin and induced tissue factor expression on monocytes as markers of diabetic microangiopathy: a prospective study on hemostasis and lipoproteins in insulin-dependent diabetes mellitus. Am J Haematol 1997; 56:93-99.
6. Holmes VA, Wallace JM, Gilmore WS, McFaul P, Alexander HD. Tissue factor expression on monocyte sub population during normal pregnancy. Thromb Haemost 2002; 87:953-958.
7. Ruf W, Edington E. Structural biology of tissue factor in the pathgenesis of atherosclerosis. FASEB J 1994; 8:385-390.
8. Rapaport SI. The extrinsic pathway inhibitor a regulator of tissue factor dependent blood coagulation. Thromb Haemost 1991; 66:6-15.
9. Osende JI, Badimon JJ, Fuster V, Herson P, Rabito P, Vidhun R, et al. Blood thrombogenicity in type 2 diabetes mellitus patients is associted with glycemic control. J Am Coll Cardiol 2001; 38:1307-1312.
10. Sowers JR, Lester MA. Diabetes and cardiovascular disease. Diabetes Care 1999; 22:14-20.
11. Del Turco S, De Caterina R. International textbook of diabetes mellitus, 2nd ed. Chichester: John Wiley; 2003. pp. 635-712.
12. Grybauskas P. Role of tissue factor in atherothrombosis. Medicina (Kaunas) 2003; 39:1165-1170.
13. Hoke M, Kyrle PA, Minar E, Bialonzcyk C, Hirschl M, Schneider B, et al. Tissue factor pathway inhibitor and the risk of recurrent venous thromboembolism. Thromb Haemost 2005; 94:787-790.
14. Bazzan M, Gruden G, Stella S, Vaccarino A, Tamponi G, Olivetti C, et al. Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activity. Diabetologia 1998; 41:767-771.
15. Zumbach M, Hofmann M, Borcea V, Luther T, Kotzch M, Muller M, et al. Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes 1997; 105:206-212.
16. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003; 107:973-977.
17. Song KS, Kim HK. Plasma levels of tissue factor antigen in patients with non-insulin-dependent diabetes mellitus. Yonsei Med J 2004; 45:38-42.
18. Sommeijer DW, Hansen HR, van Oerle R, Hamulyak K, van Zanten AP, Meesters E, et al. Soluble tissue factor is a candidate marker for progression of microvascular disease in patients with type 2 diabetes. J Thromb Haemost 2006; 4:574-580.
19. Vaidyula VR, Rao AK, Mozzoli M, Homko C, Cheung P, Boden G. Effects of hyperglycemia and hyperinsulinemia on circulating tissue factor procoagulant activity and platelet CD40 ligand. Diabetes 2006; 55:202-208.
20. Rao AKL, Chouhan V, Chen X, Sun I, Boden G. Activation of the tissue factor pathway of blood coagulation during prolonged hyperglycemia in young healthy men. Diabetes 1999; 48:1156-1161.
21. Vambergue A, Rugeri L, Caveriaux V, Devos P, Martin A, Fermon O, et al. Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age. Thromb Res 2001; 101:367-375.
22. Yokoyama H, Myrup B, Rossing P, Ostergaard PB. Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy. Diabetes Care 1996; 19:441-445.
23. Ludwig S, Dharmalingam S, Erickson-Nesmith S, Ren S, Zhu F, Ma GM, et al. Impact of simvastatin on hemostatic and fibrinolytic regulators in type 2 diabetes mellitus. Diabetes Res Clin Pract 2005; 70:110-118.
24. Rigla M, Mateo J, Fontcuberta J, Souto JC, de Leiva A, Perez A. Normalization of tissue factor pathway inhibitor activity after glycaemic control optimization in type I diabetic patients. Thromb Haemost 2000; 84:223-227.